Viewing Study NCT05197712


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2025-12-26 @ 10:19 PM
Study NCT ID: NCT05197712
Status: UNKNOWN
Last Update Posted: 2023-05-24
First Post: 2022-01-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease
Sponsor: Baiya Phytopharm Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module